| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/13/2013 | WO2013033234A9 Molecular markers associated with aphid resistance in soybean |
| 06/13/2013 | WO2013032917A3 Methods and compositions for determining smoking status |
| 06/13/2013 | WO2013022203A3 Method for detecting nucleic acid using intercalator-conjugated metal nanoparticles |
| 06/13/2013 | WO2013015609A3 Method and kit for detecting human papilloma virus |
| 06/13/2013 | WO2013010999A9 Method and system for analyzing a liquid cell sample by digital holographic microscopy |
| 06/13/2013 | WO2012174192A3 Method of amplifying a nucleic acid |
| 06/13/2013 | WO2012068511A8 Method for amplification-free nucleic acid detection on optofluidic chips |
| 06/13/2013 | WO2012056451A9 Peripheral blood gene markers for early diagnosis of parkinson's disease |
| 06/13/2013 | WO2008016988A9 Methods of nonspecific target capture of nucleic acids |
| 06/13/2013 | US20130150429 P27kip1 as a molecular marker for suitability and efficacy of treatment with hsp27 inhibitors |
| 06/13/2013 | US20130150426 Methods of diagnosing and treating idiopathic pulmonary fibrosis |
| 06/13/2013 | US20130150336 Methods For Reducing Superoxide Anions in Eukaryotic Organisms |
| 06/13/2013 | US20130150308 Vh4 codon signature for multiple sclerosis |
| 06/13/2013 | US20130150264 Methods, Kits and Compositions Pertaining to the Suppression of the Detectable Probe Binding to Randomly Distributed Repeat Sequences Genomic Nucleic Acid |
| 06/13/2013 | US20130150263 Human t2r nucleic acid sequences |
| 06/13/2013 | US20130150262 Method and Kit for Identifying Compounds Capable of Inhibiting Human Papilloma Virus Replication |
| 06/13/2013 | US20130150258 Prognosis and therapy predictive markers and methods of use |
| 06/13/2013 | US20130150255 Dna methylation biomarkers of lung function |
| 06/13/2013 | US20130150254 Reagents and methods for direct labeling of nucleotides |
| 06/13/2013 | US20130150253 Diagnostic processes that factor experimental conditions |
| 06/13/2013 | US20130150252 Detection and measurement of tissue-infiltrating lymphocytes |
| 06/13/2013 | US20130150250 Risk factors of cigarette smoke-induced spirometric phenotypes |
| 06/13/2013 | US20130150249 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| 06/13/2013 | US20130150248 Arrays of Nucleic Acid Probes for Analyzing Biotransformation Genes |
| 06/13/2013 | US20130149739 Detection and enumeration of microorganisms |
| 06/13/2013 | US20130149738 Microbial detection system and methods |
| 06/13/2013 | US20130149737 System and method for sorting cells |
| 06/13/2013 | US20130149736 Methods for sorting particles |
| 06/13/2013 | US20130149735 Microfluidic assay in idealized microvascular network for characterization of leukocyte adhesion cascade |
| 06/13/2013 | US20130149733 Establishment of rhesus monkey model of autoimmunity type 1 diabetes |
| 06/13/2013 | US20130149731 Apparatus for culturing cell and analyzing cell reaction, and method of analyzing cell reaction using the same |
| 06/13/2013 | US20130149729 Quantification of non-reducing end glycan residual compounds |
| 06/13/2013 | US20130149728 Oral Fluid Sample Collection Device With Indicator and Method |
| 06/13/2013 | US20130149727 Method for isolating urea while removing objectionable co2 |
| 06/13/2013 | US20130149719 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and Their Use as Diagnostic Reagents |
| 06/13/2013 | US20130149718 Methods of determining cellular chemosensitivity |
| 06/13/2013 | US20130149711 BARD1 Isoforms in Lung and Colorectal Cancer and Use Thereof |
| 06/13/2013 | US20130149710 Microdroplet-manipulation systems and methods for automated execution of molecular biological protocols |
| 06/13/2013 | US20130149709 Solid gel amplification method and apparatus for genotyping and pathogen detection |
| 06/13/2013 | US20130149708 Multiplex PCR for Identification of B. anthracis and Detection of Plasmid Presence |
| 06/13/2013 | US20130149706 Optical reporter compositions |
| 06/13/2013 | US20130149705 Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample |
| 06/13/2013 | US20130149704 Materials and methods for diagnosis of malignant melanoma and prognosis of metastasis of malignant melanoma |
| 06/13/2013 | US20130149703 "markers for prostate cancer progression" |
| 06/13/2013 | US20130149702 Primer set, method and kit for detecting pathogen in fish |
| 06/13/2013 | US20130149701 Methods of identifying therapeutic agents for treating persister and bacterial infection |
| 06/13/2013 | US20130149698 Stable compositions for nucleic acid amplification and sequencing |
| 06/13/2013 | US20130149697 Detection of hpv |
| 06/13/2013 | US20130149695 Method for detecting genetic mutation by using a blocking primer |
| 06/13/2013 | US20130149539 Tuned multifunctional magnetic nanoparticles for biomedicine |
| 06/13/2013 | US20130149397 Modulation of Thymosin Beta-4 in Skin |
| 06/13/2013 | US20130149373 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| 06/13/2013 | US20130149371 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 06/13/2013 | US20130149324 Therapeutic tb vaccine |
| 06/13/2013 | US20130149320 Asf1b as a Prognosis Marker and Therapeutic Target in Human Cancer |
| 06/13/2013 | US20130149319 Anticancer composition |
| 06/13/2013 | US20130149314 p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth |
| 06/13/2013 | US20130149309 Novel regulatory proteins and inhibitors |
| 06/13/2013 | DE102011121069A1 Vakzinierung mittels rekombinanter Hefe durch Erzeugung einer protektiven humoralen Immunantwort gegen definierte Antigene Vaccination using recombinant yeast by producing a protective humoral immune response against defined antigens |
| 06/13/2013 | CA2858383A1 Predicting prognosis in classic hodgkin lymphoma |
| 06/13/2013 | CA2858382A1 Mirnas useful to reduce lung cancer tumorigenesis and chemotherapy resistance and related compositons and methods |
| 06/13/2013 | CA2858202A1 Giant porphyrin-phospholipid vesicles |
| 06/13/2013 | CA2858144A1 Methods of detecting mutations and epigenetic changes |
| 06/13/2013 | CA2858082A1 Method and device for sample processing |
| 06/13/2013 | CA2858070A1 Diagnosis of lymphoid malignancies and minimal residual disease detection |
| 06/13/2013 | CA2858009A1 Respiratory infection assay |
| 06/13/2013 | CA2855921A1 Method of determination of cancer cell drug sensitivity towards aurora kinase inhibitors |
| 06/13/2013 | CA2853138A1 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 06/12/2013 | EP2602333A1 System and instrument for processing biological samples and manipulating liquids having biological samples |
| 06/12/2013 | EP2602332A1 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 06/12/2013 | EP2602331A1 Diagnostic reagent embedded in wax as an internal standard for nucleic acid preparation or nucleic acid detection |
| 06/12/2013 | EP2602330A1 Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors and overcoming their resistance |
| 06/12/2013 | EP2602322A1 Induction of exon skipping in eukaryotic cells |
| 06/12/2013 | EP2602318A1 Amadoriase having altered substrate specificity |
| 06/12/2013 | EP2602018A1 Compartmentalised screening by microfluidic control |
| 06/12/2013 | EP2601611A1 Methods for predicting stability and melting temperatures of nucleic acid duplexes |
| 06/12/2013 | EP2601530A2 Compositions and methods for detecting, diagnosing, and treating cancer |
| 06/12/2013 | EP2601528A1 Novel methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor |
| 06/12/2013 | EP2601527A1 Methods for the identification of methyltransferase interacting molecules and for the purification of methyltransferase proteins |
| 06/12/2013 | EP2601521A1 Identification of t cell target antigens |
| 06/12/2013 | EP2601315A2 Prediction of and monitoring cancer therapy response based on gene expression profiling |
| 06/12/2013 | EP2601314A1 Prognostic gene signatures for non-small cell lung cancer |
| 06/12/2013 | EP2601313A1 Prediction of hcv viral kinetics in interferon-free treatment |
| 06/12/2013 | EP2601312A1 Production of closed linear dna using a palindromic sequence |
| 06/12/2013 | EP2601311A2 Assay systems for determination of source contribution in a sample |
| 06/12/2013 | EP2601310A2 Assay systems for genetic analysis |
| 06/12/2013 | EP2601309A2 Ligation-based detection of genetic variants |
| 06/12/2013 | EP2601308A1 Aspp2 splicing variant |
| 06/12/2013 | EP2601307A1 Microarray-based assay integrated with particles for analyzing molecular interactions |
| 06/12/2013 | EP2601306A1 A sequence specific for phytoplasma causing bois noir (bn), uses thereof and bn diagnostic kits |
| 06/12/2013 | EP2601305A1 A sequence specific for flavescence doree (fd) phytoplasma, uses thereof and fd diagnostic kits |
| 06/12/2013 | EP2601304A1 Mass spectrometric diagnosis of sepsis without blood culture |
| 06/12/2013 | EP2601286A2 Pressurizable cartridge for polymerase chain reactions |
| 06/12/2013 | EP2601212A1 Methods and compounds for the diagnosis and treatment of |
| 06/12/2013 | EP2601203A1 Fatty acid esters of carotenoid glucosides as colouring agents for foodstuffs |
| 06/12/2013 | EP2600974A1 Systems, devices and methods for monitoring and detection of chemical reactions |
| 06/12/2013 | EP2600894A1 Modified hepatitis c virus proteins |
| 06/12/2013 | EP2600761A2 Biosensor membrane composition, biosensor, and methods for making same |
| 06/12/2013 | CN1922332B Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 06/12/2013 | CN1921885B Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |